Liver International

Managing chronic hepatitis C in the difficult-to-treat patient
pp. 1297-1310(14)
Authors: Kemmer, Nyingi; Neff, Guy W.

Lentivirus-mediated superoxide dismutase1 gene delivery protects against oxidative stress-induced liver injury in mice
pp. 1311-1322(12)
Authors: Venugopal, Senthil Kumar; Wu, Jian; Catana, Andreea M.; Eisenbud, Lauren; He, Song-Qing; Duan, Yu-You; Follenzi, Antonia; Zern, Mark A.

Timing of ischaemia/reperfusion before hepatectomy without inflow occlusion determines liver damage in rats: role of heat shock protein 70
pp. 1323-1332(10)
Authors: Nakamura, Ikuo; Isaji, Shuji; Yamagiwa, Kentaro; Hamada, Takashi; Uemoto, Shinji

A surgical model of fulminant hepatic failure in rabbits
pp. 1333-1341(9)
Authors: Hung, Kuo-Chen; Yong, Chee-Chien; Chen, Yaw-Sen; Eng, Hock-Liew; Kuo, Fang-Ying; Lin, Chi-Chang; Young, Tai-Horng; Kobayashi, Eiji; Chen, Chao-Long; Wang, Chih-Chi

Methylprednisolone injection via the portal vein suppresses inflammation in acute liver failure induced in rats by lipopolysaccharide andd-galactosamine
pp. 1342-1348(7)
Authors: Higuchi, Nobito; Kato, Masaki; Kotoh, Kazuhiro; Kohjima, Motoyuki; Aishima, Shinichi; Nakamuta, Makoto; Fukui, Yoshinori; Takayanagi, Ryoichi; Enjoji, Munechika

Changes in serum hepatitis B e antigen (HBeAg) levels associated with the emergence of YMDD mutants in HBeAg non-seroconverted patients during lamivudine therapy
pp. 1349-1355(7)
Authors: Yen, Yi-Hao; Lu, Sheng-Nan; Chen, Chien-Hung; Wang, Jing-Houng; Wu, Chun-Mei; Hung, Chao-Hung; Tseng, Po-lin; Hu, Tsung-Hui; Changchien, Chi-Sin; Lee, Chuan-Mo

Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers
pp. 1356-1363(8)
Authors: Tong, Myron J.; Blatt, Lawrence M.; Kao, Jia-Horng; Cheng, Jason Tzuying; Corey, William G.

Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation
pp. 1364-1370(7)
Authors: Dai, Chia-Yen; Yu, Ming-Lung; Hsieh, Ming-Yen; Lee, LI-Po; Hou, Nai-Jen; Huang, Jee-Fu; Chen, Shinn-Cherng; Lin, Zu-Yau; Hsieh, Ming-Yuh; Wang, Liang-Yen; Tsai, Jun-Fa; Chang, Wen-Yu; Chuang, Wan-Long

Evolution of hepatitis C virus infection under host factor influence in an ethnically complex population
pp. 1371-1378(8)
Authors: Cursino-Santos, Jeny R.; Donadi, Eduardo A.; Martinelli, Ana L. C.; Louzada, Paulo; Martinez-Rossi, Nilce M.

Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease
pp. 1379-1388(10)
Authors: Vizzutti, Francesco; Arena, Umberto; Rega, Luigi; Romanelli, Roberto Giulio; Colagrande, Stefano; Cuofano, Stefania; Moscarella, Stefania; Belli, Giacomo; Marra, Fabio; Laffi, Giacomo; Pinzani, Massimo

Treatment of chronic portosystemic encephalopathy in cirrhotic patients by embolization of portosystemic shunts
pp. 1389-1393(5)
Authors: Zidi, Sémia H.; Zanditenas, David; Gelu-Siméon, Moana; Rangheard, Anne-Sophie; Valla, Dominique C.; Vilgrain, Valérie; Pelletier, Gilles M.

Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry
pp. 1394-1401(8)
Authors: Ko, Cynthia; Siddaiah, Narendra; Berger, Jose; Gish, Robert; Brandhagen, David; Sterling, Richard K.; Cotler, Scott J.; Fontana, Robert J.; McCashland, Timothy M.; Han, Steven H. B.; Gordon, Frederic D.; Schilsky, Michael L.; Kowdley, Kris V.

The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid
pp. 1402-1408(7)
Authors: Desmond, Christopher Paul; Wilson, John; Bailey, Michael; Clark, Denise; Roberts, Stuart Keith

Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela
pp. 1409-1416(8)
Authors: Fortes, María del Pilar; Machado, Irma V.; Gil, Gisselle; Fernández-Mestre, Mercedes; Dagher, Lucy; León, Roberto V.; Bianco, Nicolás E.; Tassinari, Paolo

Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudine-resistant HBV reactivation following hepatitis B surface antigen seroconversion
pp. 1417-1421(5)
Authors: Gérolami, René; Borentain, Patrick; Colson, Philippe; Norguet, Emmanuelle; Gérolami, André; Tamalet, Catherine

Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period
pp. 1422-1427(6)
Authors: Nishide, Tomohiro; Ikeda, Kenji; Kawamura, Yusuke; Hosaka, Tetsuya; Kobayashi, Masahiro; Suzuki, Yoshiyuki; Kumada, Hiromitsu

Case of rapidly progressed sarcomatoid hepatocellular carcinoma in a young female without risk factor
pp. 1428-1430(3)
Authors: Inoue, Tatsuo; Kudo, Masatoshi; Minami, Yasunori; Chung, Hobyung; Fukunaga, Toyokazu; Kawasaki, Toshihiko

Hepatocellular carcinoma with situs inversus totalis and polysplenia syndrome
pp. 1430-1431(2)
Authors: Li, Tao; Wang, Lu; Chen, Rong-Xin; Ye, Qing-Hai; Sun, Hui-Chuan; Qin, Lun-Xiu; Tang, Zhao-You

Announcement
pp. 1432-1432(1)